uniQure N.V. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
37.14 M |
Public Float |
- |
uniQure N.V. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$2.48 |
Market Cap |
$2.85 B |
Shares Outstanding |
37.63 M |
Public Float |
20.95 M |
Address |
Paasheuvelweg 25a Amsterdam Noord-Holland 1105 BP Netherlands |
Employees | - |
Website | http://www.uniqure.com |
Updated | 07/08/2019 |
uniQure NV engages in the research, development, and commercialization of gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded on January 9, 2012 and is headquartered in Amsterdam, the Netherlands. |